GlaxoSmithKline Pakistan Limited is a Pakistan-based pharmaceutical company. The Company is engaged in manufacturing and marketing of research based ethical specialties, other pharmaceutical and consumer products. The Company operates through two segments: Pharmaceuticals and consumer healthcare. The Company's Pharmaceuticals segment includes prescription drugs and vaccines. The Company's consumer healthcare segment includes over-the-counter-medicines, oral care and nutritional care. In Pakistan, the Company deals in anti-infective, respiratory, vaccines, dermatological, analgesics, oncology, urology, central nervous system, allergy, cardiovascular and vitamins therapy areas. The Company's pharmaceutical brands include Augmentin, Seretide, Amoxil, Velosef, Zantac and Calpol, and consumer healthcare brands, which include Panadol, Horlicks, Sensodyne and ENO. Its vaccines include Synflorix, Infanrix Hexa, Rotarix, Havrix and Priorix Tetra.
MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.
For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.
MarketLine’ holistic business intelligence report collection includes:
Industry Intelligence
‒ Industry Profiles
‒ Market Forecasts
‒ Porter’s Five Forces Analysis
Company Intelligence
‒ Company Profiles
‒ SWOT Analysis
‒ Financial Deals
Country and City Intelligence
‒ Country and City Profiles
‒ PEST/PESTLE Analysis
‒ Socio and macro-economic indicators
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.